Detalhe da pesquisa
1.
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry.
Cancer Cell Int
; 22(1): 350, 2022 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376842
2.
Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
J Mol Diagn
; 23(4): 467-483, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577993